Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Dominique Velin"'
Autor:
Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, Edouard Auclin, Justin Panasci, Myriam Benlaifaoui, Mayra Ponce, Afnan Al-Saleh, Wiam Belkaid, Sabrine Naimi, Catalin Mihalcioiu, Ian Watson, Mickael Bouin, Wilson Miller, Marie Hudson, Matthew K. Wong, Rossanna C. Pezo, Simon Turcotte, Karl Bélanger, Rahima Jamal, Paul Oster, Dominique Velin, Corentin Richard, Meriem Messaoudene, Arielle Elkrief, Bertrand Routy
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
The microbiome is now regarded as one of the hallmarks of cancer and several strategies to modify the gut microbiota to improve immune checkpoint inhibitor (ICI) activity are being evaluated in clinical trials. Preliminary data regarding the upper ga
Externí odkaz:
https://doaj.org/article/adb7b6925dfe48898a2dcd6d9e30f8ad
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Helicobacter pylori infects the gastric mucosa of a large number of humans. Although asymptomatic in the vast majority of cases, H pylori infection can lead to the development of peptic ulcers gastric adenocarcinoma and mucosa-associated lymphoid tis
Externí odkaz:
https://doaj.org/article/bfd84d6a54654fbcab4fffc7b0e4a620
Autor:
Christina Begka, Céline Pattaroni, Catherine Mooser, Stéphane Nancey, Kathy D. McCoy, Dominique Velin, Michel H. Maillard
Publikováno v:
iScience, Vol 23, Iss 3, Pp - (2020)
Summary: Expression of Toll-interacting protein (Tollip), a potent TLR modulator, decreases in patients with inflammatory bowel diseases (IBD), whereas Tollip−/− mice are susceptible to colitis. Tollip expression was shown to be reduced in sporad
Externí odkaz:
https://doaj.org/article/3999a74983f74f58a5fbe88a027097d9
Autor:
Mati Moyat, Dominique Velin
Publikováno v:
Toxins, Vol 8, Iss 6, p 181 (2016)
One of the major toxins secreted by H. pylori is the Vacuolating cytotoxin A (VacA) named after its ability to induce the formation of “vacuole”-like membrane vesicles in the cytoplasm of gastric cells. VacA has been associated with the disruptio
Externí odkaz:
https://doaj.org/article/f3fd277331cb45b9b9ab36b0eccea3be
Autor:
Bertrand Routy, Bastien Castagner, André Marette, Arielle Elkrief, Guido Kroemer, Sylvere Durand, Emmanuelle Le Chatelier, Oscar Gitton-Quent, Florian Plaza Oñate, Geneviève Pilon, Emilia Liana Falcone, Yves V. Brun, David T. Kysela, Sandy Chevrier, Romain Boidot, François Ghiringhelli, Didier Raoult, Paul Oster, Dominique Velin, Lharbi Dridi, Yves Fradet, Stephane Isnard, Wiam Belkaid, Julie Malo, Florent Cauchois, Alexis Nolin-Lapalme, Myriam Benlaifaoui, Khoudia Diop, Mayra Ponce, Corentin Richard, Reilly Pidgeon, Meriem Messaoudene
Supplementary Figure from A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d53878c67784949fac07f86d3d9c437
https://doi.org/10.1158/2159-8290.22541432.v1
https://doi.org/10.1158/2159-8290.22541432.v1
Autor:
Bertrand Routy, Bastien Castagner, André Marette, Arielle Elkrief, Guido Kroemer, Sylvere Durand, Emmanuelle Le Chatelier, Oscar Gitton-Quent, Florian Plaza Oñate, Geneviève Pilon, Emilia Liana Falcone, Yves V. Brun, David T. Kysela, Sandy Chevrier, Romain Boidot, François Ghiringhelli, Didier Raoult, Paul Oster, Dominique Velin, Lharbi Dridi, Yves Fradet, Stephane Isnard, Wiam Belkaid, Julie Malo, Florent Cauchois, Alexis Nolin-Lapalme, Myriam Benlaifaoui, Khoudia Diop, Mayra Ponce, Corentin Richard, Reilly Pidgeon, Meriem Messaoudene
Several approaches to manipulate the gut microbiome for improving the activity of cancer immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral supplementation with the polyphenol-rich berry camu-camu (CC; Myrciari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774cbed002cf5fe66d2f547187bce8cc
https://doi.org/10.1158/2159-8290.c.6549638
https://doi.org/10.1158/2159-8290.c.6549638
Autor:
Erika Riva, Emeric Limagne, Marine M Leblond, Meriem Messaoudene, Brynn McMillan, Laurie Vaillant, Dominique Velin, Caroline Truntzer, Elisavet Machremi, Bertrand Routy, François Ghiringhelli, Gregory Verdeil, Paul Oster, Corentin Richard, Christina Begka
Publikováno v:
Gut. 71:457-466
ObjectiveIn this study, we determined whether Helicobacter pylori (H. pylori) infection dampens the efficacy of cancer immunotherapies.DesignUsing mouse models, we evaluated whether immune checkpoint inhibitors or vaccine-based immunotherapies are ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c379ebc531bf58a703dcd714d14644f
https://doi.org/10.1136/gutjnl-2020-323392
https://doi.org/10.1136/gutjnl-2020-323392
Publikováno v:
Vaccine. 39:3590-3601
Helicobacter pylori (Hp) colonizes the human gastric mucosa with a high worldwide prevalence. Currently, Hp can be eradicated by the use of antibiotics. Due to the increase of antibiotic resistance, new therapeutic strategies need to be devised: one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a37556f24946f98525a3d53e6573f8be
https://doi.org/10.1016/j.vaccine.2021.05.034
https://doi.org/10.1016/j.vaccine.2021.05.034
Publikováno v:
Helicobacter, vol. 27, no. 2, pp. e12875
Helicobacter pylori (H. pylori) colonizes the human gastric mucosa with a high worldwide prevalence. Currently, H. pylori is eradicated by the use of antibiotics. However, elevated antibiotic resistance suggests new therapeutic strategies need to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7983b9250c48e42acf010db2f7f09ac1
https://doi.org/10.1111/hel.12875
https://doi.org/10.1111/hel.12875
Autor:
Meriem Messaoudene, Reilly Pidgeon, Corentin Richard, Mayra Ponce, Khoudia Diop, Myriam Benlaifaoui, Alexis Nolin-Lapalme, Florent Cauchois, Julie Malo, Wiam Belkaid, Stephane Isnard, Yves Fradet, Lharbi Dridi, Dominique Velin, Paul Oster, Didier Raoult, François Ghiringhelli, Romain Boidot, Sandy Chevrier, David T. Kysela, Yves V. Brun, Emilia Liana Falcone, Geneviève Pilon, Florian Plaza Oñate, Oscar Gitton-Quent, Emmanuelle Le Chatelier, Sylvere Durand, Guido Kroemer, Arielle Elkrief, André Marette, Bastien Castagner, Bertrand Routy
Publikováno v:
Cancer Discovery
Cancer Discovery, 2022, 12 (4), pp.1070-1087. ⟨10.1158/2159-8290.CD-21-0808⟩
Cancer Discovery, 2022, 12 (4), pp.1070-1087. ⟨10.1158/2159-8290.CD-21-0808⟩
Several approaches to manipulate the gut microbiome for improving the activity of cancer immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral supplementation with the polyphenol-rich berry camu-camu (CC; Myrciari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a105952b8704bcf86e6485365a5ab9
https://doi.org/10.1158/2159-8290.CD-21-0808
https://doi.org/10.1158/2159-8290.CD-21-0808